Massive 10,000-Person study tracks eczema treatments in real life

NCT ID NCT04504955

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: CorEvitas Source: ClinicalTrials.gov ↗

First seen Feb 15, 2026 · Last updated Apr 16, 2026 · Updated 10 times

Summary

This study is creating a large national registry of 10,000 adults with atopic dermatitis (eczema) to track their health over time. Its main purpose is to compare the real-world safety and effectiveness of different approved eczema medications that people are already using. Researchers will collect information from patients and their doctors during regular check-ups to understand how treatments work outside of clinical trials.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • CorEvitas, LLC

    Waltham, Massachusetts, 02451, United States

Conditions

Explore the condition pages connected to this study.